Multigene profiling in incidentally- and clinically detected prostate cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component ...
PCa bone metastases. Radium-223, an alpha emitter, but not strontium-89, a beta emitter, improves survival and decreases the risk of symptomatic skeletal events in patients with bone metastases from ...
Strontium89 (Strontium Chloride Sr-89 injection), a radiopharmaceutical indicated for the relief of bone pain in patients with painful skeletal metastases, has been made available by Q BioMed.